Which has preferable valuation and earnings, IBTA or KR?

Kroger has higher revenue and earnings than Ibotta. Ibotta is trading at a lower price-to-earnings ratio than Kroger, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ibotta $342.39M 1.41 $3.58M -$0.34 N/A Kroger $147.64B 0.24 $1.02B $1.70 34.01

Is IBTA or KR more profitable?

Kroger has a net margin of 0.71% compared to Ibotta's net margin of -2.15%. Kroger's return on equity of 44.33% beat Ibotta's return on equity. Company Net Margins Return on Equity Return on Assets Ibotta -2.15% -2.39% -1.34% Kroger 0.71% 44.33% 6.20%

Which has preferable valuation and earnings, ASTH or IBTA?

Astrana Health has higher revenue and earnings than Ibotta. Ibotta is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Astrana Health $3.53B 0.56 $22.49M $0.61 58.30 Ibotta $342.39M 1.41 $3.58M -$0.34 N/A

Is ASTH or IBTA more profitable?

Astrana Health has a net margin of 0.86% compared to Ibotta's net margin of -2.15%. Astrana Health's return on equity of 9.22% beat Ibotta's return on equity. Company Net Margins Return on Equity Return on Assets Astrana Health 0.86% 9.22% 3.54% Ibotta -2.15% -2.39% -1.34%

Which has better earnings and valuation, IBTA or FLYW?

Flywire has higher revenue and earnings than Ibotta. Ibotta is trading at a lower price-to-earnings ratio than Flywire, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ibotta $342.39M 1.41 $3.58M -$0.34 N/A Flywire $623.03M 3.17 $13.50M $0.23 69.61

Is IBTA or FLYW more profitable?

Flywire has a net margin of 4.45% compared to Ibotta's net margin of -2.15%. Flywire's return on equity of 3.78% beat Ibotta's return on equity. Company Net Margins Return on Equity Return on Assets Ibotta -2.15% -2.39% -1.34% Flywire 4.45% 3.78% 2.61%

Which has better valuation & earnings, FIVN or IBTA?

Five9 has higher revenue and earnings than Ibotta. Ibotta is trading at a lower price-to-earnings ratio than Five9, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Five9 $1.15B 1.83 $39.42M $0.66 41.68 Ibotta $342.39M 1.41 $3.58M -$0.34 N/A

Is FIVN or IBTA more profitable?

Five9 has a net margin of 4.87% compared to Ibotta's net margin of -2.15%. Five9's return on equity of 12.66% beat Ibotta's return on equity. Company Net Margins Return on Equity Return on Assets Five9 4.87% 12.66% 5.52% Ibotta -2.15% -2.39% -1.34%

Which has stronger valuation & earnings, IBTA or STGW?

Stagwell has higher revenue and earnings than Ibotta. Ibotta is trading at a lower price-to-earnings ratio than Stagwell, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ibotta $342.39M 1.41 $3.58M -$0.34 N/A Stagwell $2.91B 0.72 $29.10M $0.06 140.83

Is IBTA or STGW more profitable?

Stagwell has a net margin of 0.53% compared to Ibotta's net margin of -2.15%. Stagwell's return on equity of 26.66% beat Ibotta's return on equity. Company Net Margins Return on Equity Return on Assets Ibotta -2.15% -2.39% -1.34% Stagwell 0.53% 26.66% 4.76%

Ibotta (IBTA) Competitors

$23.85 -2.54 (-9.62%)

As of 07/31/2026 03:58 PM Eastern

Compare

IBTA vs. KR, ASTH, FLYW, FIVN, and STGW

Should you buy Ibotta stock or one of its competitors? MarketBeat compares Ibotta with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Ibotta include Kroger (KR), Astrana Health (ASTH), Flywire (FLYW), Five9 (FIVN), and Stagwell (STGW).

How does Ibotta compare to Kroger?

Ibotta (NYSE:IBTA) and Kroger (NYSE:KR) are related companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

Kroger has a net margin of 0.71% compared to Ibotta's net margin of -2.15%. Kroger's return on equity of 44.33% beat Ibotta's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ibotta	-2.15%	-2.39%	-1.34%
Kroger	0.71%	44.33%	6.20%

Ibotta has a beta of -0.59, meaning that its stock price is 159% less volatile than the broader market. Comparatively, Kroger has a beta of 0.44, meaning that its stock price is 56% less volatile than the broader market.

Kroger has higher revenue and earnings than Ibotta. Ibotta is trading at a lower price-to-earnings ratio than Kroger, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ibotta	$342.39M	1.41	$3.58M	-$0.34	N/A
Kroger	$147.64B	0.24	$1.02B	$1.70	34.01

Ibotta currently has a consensus price target of $33.83, suggesting a potential upside of 41.86%. Kroger has a consensus price target of $72.00, suggesting a potential upside of 24.52%. Given Ibotta's higher possible upside, equities analysts clearly believe Ibotta is more favorable than Kroger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ibotta	3 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.80
Kroger	0 Sell rating(s)	9 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.53

80.9% of Kroger shares are held by institutional investors. 20.9% of Ibotta shares are held by insiders. Comparatively, 0.4% of Kroger shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Kroger had 40 more articles in the media than Ibotta. MarketBeat recorded 40 mentions for Kroger and 0 mentions for Ibotta. Kroger's average media sentiment score of 0.77 beat Ibotta's score of 0.00 indicating that Kroger is being referred to more favorably in the news media.

Company	Overall Sentiment
Ibotta	Neutral
Kroger	Positive

Summary

Kroger beats Ibotta on 13 of the 16 factors compared between the two stocks.

How does Ibotta compare to Astrana Health?

Astrana Health (NASDAQ:ASTH) and Ibotta (NYSE:IBTA) are related small-cap companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

Astrana Health has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market. Comparatively, Ibotta has a beta of -0.59, indicating that its stock price is 159% less volatile than the broader market.

In the previous week, Astrana Health had 4 more articles in the media than Ibotta. MarketBeat recorded 4 mentions for Astrana Health and 0 mentions for Ibotta. Astrana Health's average media sentiment score of 0.88 beat Ibotta's score of 0.00 indicating that Astrana Health is being referred to more favorably in the media.

Company	Overall Sentiment
Astrana Health	Positive
Ibotta	Neutral

Astrana Health has higher revenue and earnings than Ibotta. Ibotta is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$3.53B	0.56	$22.49M	$0.61	58.30
Ibotta	$342.39M	1.41	$3.58M	-$0.34	N/A

Astrana Health has a net margin of 0.86% compared to Ibotta's net margin of -2.15%. Astrana Health's return on equity of 9.22% beat Ibotta's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	0.86%	9.22%	3.54%
Ibotta	-2.15%	-2.39%	-1.34%

Astrana Health presently has a consensus target price of $47.86, suggesting a potential upside of 34.58%. Ibotta has a consensus target price of $33.83, suggesting a potential upside of 41.86%. Given Ibotta's higher possible upside, analysts plainly believe Ibotta is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78
Ibotta	3 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.80

52.8% of Astrana Health shares are owned by institutional investors. 20.3% of Astrana Health shares are owned by insiders. Comparatively, 20.9% of Ibotta shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Astrana Health beats Ibotta on 13 of the 16 factors compared between the two stocks.

How does Ibotta compare to Flywire?

Ibotta (NYSE:IBTA) and Flywire (NASDAQ:FLYW) are related small-cap companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, dividends, valuation, institutional ownership and earnings.

Flywire has a net margin of 4.45% compared to Ibotta's net margin of -2.15%. Flywire's return on equity of 3.78% beat Ibotta's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ibotta	-2.15%	-2.39%	-1.34%
Flywire	4.45%	3.78%	2.61%

Flywire has higher revenue and earnings than Ibotta. Ibotta is trading at a lower price-to-earnings ratio than Flywire, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ibotta	$342.39M	1.41	$3.58M	-$0.34	N/A
Flywire	$623.03M	3.17	$13.50M	$0.23	69.61

95.9% of Flywire shares are owned by institutional investors. 20.9% of Ibotta shares are owned by company insiders. Comparatively, 5.0% of Flywire shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Ibotta currently has a consensus target price of $33.83, suggesting a potential upside of 41.86%. Flywire has a consensus target price of $18.69, suggesting a potential upside of 16.75%. Given Ibotta's higher possible upside, analysts plainly believe Ibotta is more favorable than Flywire.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ibotta	3 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.80
Flywire	0 Sell rating(s)	7 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.53

Ibotta has a beta of -0.59, indicating that its share price is 159% less volatile than the broader market. Comparatively, Flywire has a beta of 1.32, indicating that its share price is 32% more volatile than the broader market.

In the previous week, Flywire had 1 more articles in the media than Ibotta. MarketBeat recorded 1 mentions for Flywire and 0 mentions for Ibotta. Flywire's average media sentiment score of 0.71 beat Ibotta's score of 0.00 indicating that Flywire is being referred to more favorably in the news media.

Company	Overall Sentiment
Ibotta	Neutral
Flywire	Positive

Summary

Flywire beats Ibotta on 14 of the 16 factors compared between the two stocks.

How does Ibotta compare to Five9?

Five9 (NASDAQ:FIVN) and Ibotta (NYSE:IBTA) are related companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations.

Five9 currently has a consensus price target of $25.93, indicating a potential downside of 5.75%. Ibotta has a consensus price target of $33.83, indicating a potential upside of 41.86%. Given Ibotta's higher possible upside, analysts clearly believe Ibotta is more favorable than Five9.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Five9	1 Sell rating(s)	7 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.50
Ibotta	3 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.80

Five9 has a beta of 1.46, meaning that its stock price is 46% more volatile than the broader market. Comparatively, Ibotta has a beta of -0.59, meaning that its stock price is 159% less volatile than the broader market.

Five9 has a net margin of 4.87% compared to Ibotta's net margin of -2.15%. Five9's return on equity of 12.66% beat Ibotta's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Five9	4.87%	12.66%	5.52%
Ibotta	-2.15%	-2.39%	-1.34%

96.6% of Five9 shares are owned by institutional investors. 1.2% of Five9 shares are owned by insiders. Comparatively, 20.9% of Ibotta shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Five9 has higher revenue and earnings than Ibotta. Ibotta is trading at a lower price-to-earnings ratio than Five9, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Five9	$1.15B	1.83	$39.42M	$0.66	41.68
Ibotta	$342.39M	1.41	$3.58M	-$0.34	N/A

In the previous week, Five9 had 10 more articles in the media than Ibotta. MarketBeat recorded 10 mentions for Five9 and 0 mentions for Ibotta. Five9's average media sentiment score of 0.23 beat Ibotta's score of 0.00 indicating that Five9 is being referred to more favorably in the media.

Company	Overall Sentiment
Five9	Neutral
Ibotta	Neutral

Summary

Five9 beats Ibotta on 14 of the 16 factors compared between the two stocks.

How does Ibotta compare to Stagwell?

Ibotta (NYSE:IBTA) and Stagwell (NASDAQ:STGW) are both communication services companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations and risk.

In the previous week, Stagwell had 17 more articles in the media than Ibotta. MarketBeat recorded 17 mentions for Stagwell and 0 mentions for Ibotta. Stagwell's average media sentiment score of 0.71 beat Ibotta's score of 0.00 indicating that Stagwell is being referred to more favorably in the news media.

Company	Overall Sentiment
Ibotta	Neutral
Stagwell	Positive

Ibotta has a beta of -0.59, suggesting that its share price is 159% less volatile than the broader market. Comparatively, Stagwell has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market.

Stagwell has a net margin of 0.53% compared to Ibotta's net margin of -2.15%. Stagwell's return on equity of 26.66% beat Ibotta's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ibotta	-2.15%	-2.39%	-1.34%
Stagwell	0.53%	26.66%	4.76%

Ibotta currently has a consensus target price of $33.83, indicating a potential upside of 41.86%. Stagwell has a consensus target price of $9.40, indicating a potential upside of 11.24%. Given Ibotta's higher probable upside, equities research analysts clearly believe Ibotta is more favorable than Stagwell.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ibotta	3 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.80
Stagwell	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

35.6% of Stagwell shares are held by institutional investors. 20.9% of Ibotta shares are held by company insiders. Comparatively, 11.2% of Stagwell shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Stagwell has higher revenue and earnings than Ibotta. Ibotta is trading at a lower price-to-earnings ratio than Stagwell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ibotta	$342.39M	1.41	$3.58M	-$0.34	N/A
Stagwell	$2.91B	0.72	$29.10M	$0.06	140.83

Summary

Stagwell beats Ibotta on 13 of the 16 factors compared between the two stocks.

Get Ibotta News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IBTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IBTA vs. The Competition

Export

Metric	Ibotta	Media Industry	Communication Services Sector	NYSE Exchange
Market Cap	$484.75M	$3.07B	$32.40B	$23.68B
Dividend Yield	N/A	5.35%	5.34%	4.22%
P/E Ratio	-70.15	36.47	227.52	31.00
Price / Sales	1.41	27.64	61.02	19.09
Price / Cash	46.71	19.82	19.53	31.30
Price / Book	1.94	7.76	10.54	4.62
Net Income	$3.58M	-$30.65M	$1.11B	$1.07B
7 Day Performance	-8.52%	2.55%	1.21%	0.35%
1 Month Performance	-32.76%	-4.42%	-2.15%	-0.55%
1 Year Performance	-31.29%	17.83%	4.71%	19.21%

Ibotta Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IBTA Ibotta	3.0494 of 5 stars	$23.85 -9.6%	$33.83 +41.9%	-31.3%	$484.75M	$342.39M	N/A	N/A	Upcoming Earnings
KR Kroger	4.4265 of 5 stars	$58.13 +2.2%	$72.00 +23.9%	-19.0%	$35.63B	$147.64B	34.21	403,000	Trending News
ASTH Astrana Health	4.5446 of 5 stars	$38.27 -5.1%	$47.86 +25.1%	+64.9%	$2.13B	$3.53B	62.64	3,000	News Coverage Positive News Upcoming Earnings
FLYW Flywire	3.1844 of 5 stars	$16.23 +2.1%	$18.69 +15.2%	+54.4%	$2.00B	$623.03M	70.54	1,400	Upcoming Earnings
FIVN Five9	3.3166 of 5 stars	$25.17 +8.8%	$25.93 +3.0%	+13.3%	$1.93B	$1.15B	38.16	2,910	News Coverage Upcoming Earnings Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:IBTA) was last updated on 8/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ibotta (IBTA) Competitors